Status:
UNKNOWN
Drug Name Identification an Ignored Patient's Problem That Needs a Solution
Lead Sponsor:
Alexandria University
Conditions:
Remember the Name of a Given Drug
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
Each of the recruited patient was given 3 different placebo drugs with 3 different mad up names to be taken for one month with different regiments. The drug name resembled a real drug but with enough...
Detailed Description
A scoring system was used to evaluate pateints memory of the drugs used 0- 3 0 is the minimal score and will be given if no recall of any drug name and 3 is the maximum score and will be given if the ...
Eligibility Criteria
Inclusion
- ASA I and II patients
Exclusion
- severe or life-threatening condition
- severe visual impairment
- mental or cognitive dysfunction
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05343234
Start Date
April 1 2022
End Date
June 1 2022
Last Update
April 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria university
Alexandria, Egypt, 0203